Latest news with #Stockhead
Herald Sun
18 hours ago
- Business
- Herald Sun
Explorers Podcast: ACM
Stockhead's 'Garimpeiro' columnist Barry FitzGerald is back in the studio for another instalment of The Explorers Podcast. In this edition, Barry catches up with Australian Critical Minerals (ASX:ACM) managing director Dean de Largie, a company which he thinks has a lot of leverage and multiple re-rating events coming on the horizon. Recent news has been the company's acquisition of advanced Peruvian assets which it considered just too good to pass up, and there are other irons in the ACM fire to keep an eye on as the company gets ready over drill-ready targets it believes have exceptional scope for discovery. This podcast was developed in collaboration with Australian Critical Minerals, a Stockhead advertiser at the time of publishing. The interviews and discussions in this podcast are opinions only and not financial or investment advice. Listeners should obtain independent advice based on their own circumstances before making any financial decisions. Originally published as Explorers Podcast: Australian Critical Minerals readies for Peruvian polymetallic perforation
Courier-Mail
19 hours ago
- Business
- Courier-Mail
Tony's Takeaway: Raiz Invest
Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. Tony Locantro has been a client advisor/investment manager in the stockbroking industry since 1998. He's focused on the small cap and emerging companies with a strong interest in identifying those in the mining, biotech and industrial sectors that offer growth potential. He also delves into the psychology of speculation and provides regular insights on a number of social media and finance related outlets. In this edition, Tony remembers some savvy investments that were lying out for all to see before turning to one he thinks could be looked back on similarly in Raiz Invest (ASX:RZI) and a customer base which is growing in more ways than one. The views, information, or opinions expressed in this video are solely those of the author and do not represent the views of Stockhead. Stockhead has not provided, endorsed or otherwise assumed responsibility for any financial product advice contained in this video. Viewers should obtain independent advice based on their own circumstances before making any financial decisions. Originally published as Tony's Takeaway: Raiz-ing the investment roof
News.com.au
21 hours ago
- Business
- News.com.au
Tony's Takeaway: Raiz-ing the investment roof
Tony Locantro has been a client advisor/investment manager in the stockbroking industry since 1998. He's focused on the small cap and emerging companies with a strong interest in identifying those in the mining, biotech and industrial sectors that offer growth potential. He also delves into the psychology of speculation and provides regular insights on a number of social media and finance related outlets. In this edition, Tony remembers some savvy investments that were lying out for all to see before turning to one he thinks could be looked back on similarly in Raiz Invest (ASX:RZI) and a customer base which is growing in more ways than one. The views, information, or opinions expressed in this video are solely those of the author and do not represent the views of Stockhead. Stockhead has not provided, endorsed or otherwise assumed responsibility for any financial product advice contained in this video. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.
News.com.au
2 days ago
- Business
- News.com.au
Break it Down: EZZ launches EZZDAY brand in US with four dietary supplements
Stockhead's Break it Down brings you today's leading market news in under 90 seconds. In this episode, host Tylah Tully unpacks EZZ Life Science (ASX:EZZ) latest news. They have officially entered one of the world's largest markets for health supplements, with the launch of its new American brand EZZDAY . Tune in to hear all about it. While EZZ Life Science is a Stockhead advertiser, it did not sponsor this content. Originally published as Break it Down: EZZ launches EZZDAY brand in US with four dietary supplements
Herald Sun
2 days ago
- Business
- Herald Sun
StockTake: Lumos Diagnostics
Stockhead's Tylah Tully unpacks the latest from Lumos Diagnostics (ASX:LDX), who have enrolled its 500th patient in a CLIA waiver study for FebriDx, its rapid point-of-care diagnostic test to differentiate between bacterial and non-bacterial acute respiratory infections. The company has a funding partnership with the US government's Biomedical Advanced Research and Development Authority (BARDA). Lumos has now received more than US$1.2 million in milestone payments from BARDA, which has pledged nearly US$3 million toward the study. Watch the video to learn more. This video was developed in collaboration with Lumos Diagnostics, a Stockhead advertiser at the time of publishing. This video does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions. Originally published as StockTake: Lumos enrols 500th patient in crucial respiratory diagnostic test study
